Synthesis, Formulation, and Characterization of Doxorubicin-Loaded Laponite/Oligomeric Hyaluronic Acid-Aminophenylboronic Acid Nanohybrids and Cytological Evaluation against MCF-7 Breast Cancer Cells


As a synthetic clay material, laponite RDS (LR) was investigated as an effective drug carrier as a result of the special nanodisk structure together with the negative-charged surface to achieve enhanced cellular uptake and targeted delivery. In this research work, the synthesized oligomeric hyaluronic acid-aminophenylboronic acid (oHA-APBA) was entangled onto LR nanodisks to fabricate a valid targeted platform for breast cancer therapy. Briefly, through the formation of amide bonds, 3-APBA was connected to the chain of oHA with a substituted ratio of 4.0 ± 0.2% to synthesize oHA-APBA copolymer. Thereafter, doxorubicin (DOX) was inserted into the interlayer space of LR by the way of the ion exchange process, followed by an assembly with oHA-APBA as a targeted protection layer. The satisfactory drug encapsulation efficiency (> 80%) and narrow size distribution were achieved. The in vitro drug release study demonstrated the release of DOX from DOX@LR/oHA-APBA was sustained and acid dependent. In addition, after fitting the drug cumulative release of DOX@LR/oHA-APBA under different pH conditions with several kinetic models, it was identified that drug release from DOX@LR/oHA-APBA nanohybrids at pH 5.0 was mainly dependent on both diffusion and ion exchange effects. However, under the condition of pH 7.4, the drug was most efficiently released by diffusion effect. Importantly, DOX@LR/oHA-APBA showed remarkable cellular uptake and intracellular drug distribution in MCF-7 cells, which were consistent with inhibitory ability against MCF-7 cells. Hence, the high DOX loading capacity and enhanced cellular tracking can enlighten LR/oHA-APBA as an effective drug delivery carrier for breast cancer therapy.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8


  1. 1.

    Wei L, Chen J, Zhao S, Ding J, Chen X. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs. Acta Biomater. 2017;58:44–53.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Li D, Feng X, Chen L, Ding J, Chen X. One-step synthesis of targeted acid-labile polysaccharide prodrug for efficiently intracellular drug delivery. ACS Biomater Sci Eng. 2018;4(2):539–46.

    CAS  Article  Google Scholar 

  3. 3.

    Zhang X, Liang N, Gong X, Kawashima Y, Cui F, Sun S. Tumor-targeting micelles based on folic acid and alpha-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery. Colloids Surf B: Biointerfaces. 2019;177:11–8.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Lee JY, Termsarasab U, Park JH, Lee SY, Ko SH, Shim JS, et al. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. J Control Release. 2016;236:38–46.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Jia X, Han Y, Pei M, Zhao X, Tian K, Zhou T, et al. Multi-functionalized hyaluronic acid nanogels crosslinked with carbon dots as dual receptor-mediated targeting tumor theranostics. Carbohydr Polym. 2016;152:391–7.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Zhang X, Zhang Z, Su X, Cai M, Zhuo R, Zhong Z. Phenylboronic acid-functionalized polymeric micelles with a HepG2 cell targetability. Biomaterials. 2013;34(38):10296–304.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 2008;41(1):120–9.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. J Control Release. 2010;143(3):374–82.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10–22.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Li D, Zhang YT, Yu M, Guo J, Chaudhary D, Wang CC. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles. Biomaterials. 2013;34(32):7913–22.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Liu ZL, Tian DY, Li SP, Li XD, Lu TH. MTX/LDHs hybrids synthesized from reverse microemulsions: particle control and bioassay study. Int J Pharm. 2014;473(1–2):414–25.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Rojas R, Giacomelli CE. Size-tunable LDH–protein hybrids toward the optimization of drug nanocarriers. J Mater Chem B. 2015;3(14):2778–85.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Ley C, Brendle J, Walter A, Jacques P, Ibrahim A, Allonas X. On the interaction of triarylmethane dye crystal violet with LAPONITE® clay: using mineral nanoparticles to control the dye photophysics. Phys Chem Chem Phys. 2015;17(26):16677–81.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Chen G, Li D, Li J, Cao X, Wang J, Shi X, et al. Targeted doxorubicin delivery to hepatocarcinoma cells by lactobionic acid-modified laponite nanodisks. New J Chem. 2015;39(4):2847–55.

    CAS  Article  Google Scholar 

  15. 15.

    Wang Je WG, Sun Y, Wang Y, Yang Y, Yuan Y, et al. In situ formation of pH−/thermo-sensitive nanohybrids via friendly-assembly of poly(N-vinylpyrrolidone) onto LAPONITE®. RSC Adv. 2016;6(38):31816–23.

    Article  Google Scholar 

  16. 16.

    Jung H, Kim HM, Choy YB, Hwang SJ, Choy JH. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole. Int J Pharm. 2008;349(1–2):283–90.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Jung H, Kim HM, Choy YB, Hwang SJ, Choy JH. Itraconazole–Laponite: kinetics and mechanism of drug release. Appl Clay Sci. 2008;40(1–4):99–107.

    CAS  Article  Google Scholar 

  18. 18.

    Wang S, Zheng F, Huang Y, Fang Y, Shen M, Zhu M, et al. Encapsulation of amoxicillin within laponite-doped poly(lactic-co-glycolic acid) nanofibers: preparation, characterization, and antibacterial activity. ACS Appl Mater Interfaces. 2012;4(11):6393–401.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Chen X, Wang Y, Chai R, Xu Y, Li H, Liu B. Luminescent lanthanide-based organic/inorganic hybrid materials for discrimination of glutathione in solution and within hydrogels. ACS Appl Mater Interfaces. 2017;9(15):13554–63.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Felbeck T, Behnke T, Hoffmann K, Grabolle M, Lezhnina MM, Kynast UH, et al. Nile-red-nanoclay hybrids: red emissive optical probes for use in aqueous dispersion. Langmuir. 2013;29(36):11489–97.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Grabolle M, Starke M, Resch-Genger U. Highly fluorescent dye-nanoclay hybrid materials made from different dye classes. Langmuir. 2016;32(14):3506–13.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Deng C, Zhang Q, Fu Y, Sun X, Gong T, Zhang Z. Coadministration of oligomeric hyaluronic acid-modified liposomes with tumor-penetrating peptide-iRGD enhances the antitumor efficacy of doxorubicin against melanoma. ACS Appl Mater Interfaces. 2017;9(2):1280–92.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Lv S, Li M, Tang Z, Song W, Sun H, Liu H, et al. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Acta Biomater. 2013;9(12):9330–42.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Ahmad N, Ahmad R, Alam MA, Ahmad FJ. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles. Chem Cent J. 2018;12(1):65.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Li JY, Yue Y, Yu YB, Li Q, Tan GX, Wang YY, et al. Laponite nanoplatform functionalized with histidine modified oligomeric hyaluronic acid as an effective vehicle for anticancer drug methotrexate. J Mater Chem B. 2018;6(30):5011–20.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Song Y, Cai H, Yin T, Huo M, Ma P, Zhou J, et al. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Int J Nanomedicine. 2018;13:1585–600.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Chen D, Lian S, Sun J, Liu Z, Zhao F, Jiang Y, et al. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv. 2016;23(3):808–13.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Dosio F, Arpicco S, Stella B, Fattal E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Deliv Rev. 2016;97:204–36.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Jeong JY, Hong EH, Lee SY, Lee JY, Song JH, Ko SH, et al. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomater. 2017;53:414–26.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Geninatti Crich S, Alberti D, Szabo I, Aime S, Djanashvili K. MRI visualization of melanoma cells by targeting overexpressed sialic acid with a Gd(III)-dota-en-pba imaging reporter. Angew Chem. 2013;52(4):1161–4.

    CAS  Article  Google Scholar 

  31. 31.

    Ahmad N, Alam MA, Ahmad R, Naqvi AA, Ahmad FJ. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Artif Cells Nanomed Biotechnol. 2018;46(2):432–46.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Ahmad N, Alam MA, Ahmad R, Umar S, Jalees Ahmad F. Improvement of oral efficacy of irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. J Microencapsul. 2018;35(4):327–43.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Ahmad N, Ahmad R, Alam MA, Ahmad FJ, Amir M, Pottoo FH, et al. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol. 2019;128:825–38.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Li X, Xing L, Hu Y, Xiong Z, Wang R, Xu X, et al. An RGD-modified hollow silica@Au core/shell nanoplatform for tumor combination therapy. Acta Biomater. 2017;62:273–83.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Alam MA, Ahmad N, Ahmad R, Talegaonkar S, Ahmad FJ, Iqbal Z, et al. Quantification of tamoxifen polymeric nanoparticles in female rodent breast tissue by UPLC/ESI-Q-TOF MS/MS. J Young Pharm. 2016;8(4):415–23.

    CAS  Article  Google Scholar 

  36. 36.

    Ahmad J, Ahmad N, Kohli K, Mir S, Amin S. Pharmacokinetic analysis of taxane through a validated ultra-high performance liquid chromatography-synapt mass spectrometry (UHPLC-MS/MS ESI-Q-TOF) method. Curr Bioact Compd. 2016;12(2):93–102.

    CAS  Article  Google Scholar 

  37. 37.

    Wang S, Wu Y, Guo R, Huang Y, Wen S, Shen M, et al. Laponite nanodisks as an efficient platform for doxorubicin delivery to cancer cells. Langmuir. 2013;29(16):5030–6.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Wu Y, Guo R, Wen S, Shen M, Zhu M, Wang J, et al. Folic acid-modified laponite nanodisks for targeted anticancer drug delivery. J Mater Chem B. 2014;2(42):7410–8.

    CAS  Article  PubMed  Google Scholar 

Download references


This work was supported by the National Natural Science Foundation Youth Science Foundation Project (81703709) and project funded by China Postdoctoral Science Foundation (2018M641716).

Author information



Corresponding author

Correspondence to Weisan Pan.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Li, J., Chen, F. et al. Synthesis, Formulation, and Characterization of Doxorubicin-Loaded Laponite/Oligomeric Hyaluronic Acid-Aminophenylboronic Acid Nanohybrids and Cytological Evaluation against MCF-7 Breast Cancer Cells. AAPS PharmSciTech 21, 5 (2020).

Download citation


  • laponite RDS
  • targeted delivery
  • oligomeric hyaluronic acid
  • 3-aminophenylboronic acid
  • breast cancer therapy